Project description:This SuperSeries is composed of the following subset Series: GSE35379: Genome-wide occupancy map of GATA-1 in proliferating and differentiating murine ES cell derived erythroid progenitors (ES-EP) GSE35384: Transcriptome analysis of differentiating normal and leukemic erythroid progenitors Refer to individual Series
Project description:affy_phloem_ath1 - affy_phloem_ath1 - Transcriptome map of a mutant (versus WT and overexpressor) impaired in phloem differentiation and vascular patterning-Transcriptome map of a mutant (versus WT and overexpressor) impaired in phloem differentiation and vascular patterning.
Project description:affy_phloem_ath1 - affy_phloem_ath1 - Transcriptome map of a mutant (versus WT and overexpressor) impaired in phloem differentiation and vascular patterning-Transcriptome map of a mutant (versus WT and overexpressor) impaired in phloem differentiation and vascular patterning. 6 arrays - ATH1
Project description:Transcriptome analysis to map transcriptomes of Mps1DK p53null-driven aneuploid T-ALL, to determine correlation between copy number changes and expression changes and to map the transcriptional response to CIN
Project description:The clinical presentation, course and treatment of methamphetamine-associated psychosis (MAP) are similar to that observed in schizophrenia (SCZ) and subsequently MAP has been hypothesized as a pharmacological and environmental model of SCZ. However, several challenges currently exist in accurately diagnosing MAP at the molecular and neurocognitive level before the MAP model can contribute to the discovery of SCZ biomarkers. We directly assessed subcortical brain structural volumes and clinical parameters of MAP within the framework of an integrative genome-wide RNA-Seq blood transcriptome analysis of subjects diagnosed with MAP (N=10), METH-dependency without psychosis (MA) (N=10) and healthy controls (N=10). We used RNA-Sequencing gene expression to characterize molecular signatures associated to METH and MAP status compared to healthy control subjects.
